Related Experiment Video
Updated: Jul 14, 2026
12:49
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Current indications and contraindications for liver transplantation
1Division of Gastroenterology and Hepatology, Liver Transplant Program, Stanford University School of Medicine, Stanford, CA 94304, USA.
Clinics in Liver Disease
|July 4, 2007
Summary
Liver transplant survival is improving due to better patient selection, surgical methods, and infection control. Ongoing research aims to refine criteria for liver transplantation, enhancing patient outcomes.
Area of Science:
- Hepatology
- Transplant Surgery
- Immunology
Background:
- Liver transplantation survival rates have significantly improved over time.
- Advancements in surgical techniques, immunosuppression, and infection management contribute to better outcomes.
- Evolving indications and contraindications for liver transplantation are crucial for patient management.
Purpose of the Study:
- To review the factors contributing to improved liver transplant survival.
- To discuss the dynamic nature of indications and contraindications in liver transplantation.
- To highlight the role of patient selection and organ allocation in liver transplant success.
Main Methods:
- Literature review of recent advancements in liver transplantation.
- Analysis of current trends in patient selection and organ allocation.
- Discussion of evolving clinical criteria for liver transplant candidacy.
Main Results:
- Earlier patient referral and selection, improved surgical techniques, advanced immunosuppression, and effective infection prevention have boosted survival rates.
- Continuous modification of indications and contraindications aims to optimize survival and functional status for patients with end-stage liver disease or acute liver failure.
- The Model for End-stage Liver Disease (MELD) score is currently used for organ allocation and may influence future patient selection criteria.
Conclusions:
- Liver transplantation outcomes have markedly improved due to a combination of medical and surgical advancements.
- Refined patient selection and evolving eligibility criteria are key to maximizing the success of liver transplantation.
- The Model for End-stage Liver Disease score plays a significant role in organ allocation and may impact future patient selection.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...